Chemed reports Q2 EPS $5.64 vs. $4.93 last year

Reports Q2 revenue $606.2M vs. $564.5M last year. VITAS segment operating results: Net Patient Revenue of $391.4 million, an increase of 17.3%, Average Daily Census (ADC) of 21,785, an increase of 15.5%, Admissions of 16,775, an increase of 6.3%. Roto-Rooter segment operating results: Revenue of $214.8 million, a decrease of 6.9%.